Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Meningococcal Vaccination

Vaccines are now available that help protect against all three serogroups (B, C, and Y) of meningococcal disease that are commonly seen in the United States:

  • Meningococcal conjugate vaccines (Menactra®, Menveo®, and MenHibrix®)
  • Meningococcal polysaccharide vaccine (Menomune®)
  • Serogroup B meningococcal vaccines (Bexsero® and Trumenba®)

For more information on meningococcal vaccines and who should receive them, visit the Meningococcal Vaccine site or Recommendations of the Advisory Committee on Immunization Practices.

What You Need to Know about Meningococcal Vaccines

Q&A on Meningococcal Vaccine Recommendations

Q&A image

In addition to meningococcal conjugate vaccination, clinicians may choose to administer a serogroup B meningococcal vaccine to patients 16 through 23 years old. See answers to common questions about these vaccine recommendations.

Meningococcal Vaccine Resources for Healthcare Professionals

Vaccination Coverage

Top of Page

Related Pages

  • Have You Heard About How To Prevent Meningococcal Disease?
    View this video on CDC-TV or on YouTube